DK0741870T3 - Fremgangsmåde til kvantificering af LBP i kropsvæsker - Google Patents

Fremgangsmåde til kvantificering af LBP i kropsvæsker

Info

Publication number
DK0741870T3
DK0741870T3 DK95909325T DK95909325T DK0741870T3 DK 0741870 T3 DK0741870 T3 DK 0741870T3 DK 95909325 T DK95909325 T DK 95909325T DK 95909325 T DK95909325 T DK 95909325T DK 0741870 T3 DK0741870 T3 DK 0741870T3
Authority
DK
Denmark
Prior art keywords
body fluids
lbp
quantifying
quantifying lbp
subject
Prior art date
Application number
DK95909325T
Other languages
Danish (da)
English (en)
Inventor
Mark Leslie White
Stephen Fitzhugh Carroll
Jeremy Kam-Kuen Ma
Original Assignee
Xoma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Corp filed Critical Xoma Corp
Application granted granted Critical
Publication of DK0741870T3 publication Critical patent/DK0741870T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/821—Chemistry: analytical and immunological testing involving complement factors or complement systems

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Peptides Or Proteins (AREA)
DK95909325T 1994-01-24 1995-01-24 Fremgangsmåde til kvantificering af LBP i kropsvæsker DK0741870T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/186,811 US5484705A (en) 1994-01-24 1994-01-24 Method for quantifying lipopolysaccharide binding protein
PCT/US1995/000982 WO1995020163A1 (en) 1994-01-24 1995-01-24 Method for quantifying lbp in body fluids

Publications (1)

Publication Number Publication Date
DK0741870T3 true DK0741870T3 (da) 1999-12-13

Family

ID=22686373

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95909325T DK0741870T3 (da) 1994-01-24 1995-01-24 Fremgangsmåde til kvantificering af LBP i kropsvæsker

Country Status (13)

Country Link
US (3) US5484705A (es)
EP (1) EP0741870B1 (es)
JP (1) JP3554331B2 (es)
CN (1) CN1132013C (es)
AT (1) ATE182216T1 (es)
AU (1) AU701710B2 (es)
DE (1) DE69510772T2 (es)
DK (1) DK0741870T3 (es)
ES (1) ES2133738T3 (es)
GR (1) GR3031303T3 (es)
HK (1) HK1015174A1 (es)
MX (1) MX9602688A (es)
WO (1) WO1995020163A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652332A (en) * 1993-03-12 1997-07-29 Xoma Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
US5891618A (en) * 1994-01-24 1999-04-06 Xoma Corporation Method for quantifying LBP in body fluids
US5484705A (en) * 1994-01-24 1996-01-16 Xoma Corporation Method for quantifying lipopolysaccharide binding protein
US5932536A (en) * 1994-06-14 1999-08-03 The Rockefeller University Compositions for neutralization of lipopolysaccharides
WO1997004008A1 (en) * 1995-07-20 1997-02-06 Xoma Corporation Anti-fungal peptides
NZ332720A (en) * 1996-05-10 2000-07-28 Xoma Corp Therapeutic uses of bactericidal/permeability increasing (BPI) protein to treat human meningococcemia
CN1155403C (zh) * 1996-05-23 2004-06-30 爱克索马技术有限公司 杀细菌／通透性增加蛋白在制备用于治疗创伤出血病人的药物中的应用
US5888973A (en) 1996-08-09 1999-03-30 Xoma Corporation Anti-chlamydial uses of BPI protein products
US6482796B2 (en) * 1996-11-01 2002-11-19 Xoma Corporation Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients
US6093573A (en) * 1997-06-20 2000-07-25 Xoma Three-dimensional structure of bactericidal/permeability-increasing protein (BPI)
US5990082A (en) 1997-10-22 1999-11-23 Xoma Corporation Uses of lipopolysaccharide binding protein
US6013631A (en) 1998-06-19 2000-01-11 Xoma Corporation Bactericidal/permeability-increasing protein (BPI) deletion analogs
US7465555B2 (en) * 2002-04-02 2008-12-16 Becton, Dickinson And Company Early detection of sepsis
AU2003291484A1 (en) * 2002-11-12 2004-06-03 Becton, Dickinson And Company Diagnosis of sepsis or sirs using biomarker profiles
BR0316231A (pt) * 2002-11-12 2005-10-04 Becton Dickinson Co Métodos para determinar o estado de sepsia para prognosticar o começo de sepsia e para diagnosticar a sìndrome de resposta inflamatória sistêmica em um indivìduo e para isolar um biomarcador, perfil biomarcador r kit
EP1565570A4 (en) * 2002-11-12 2005-12-28 Becton Dickinson Co DIAGNOSIS OF SEPTICEMIA OR SIRS USING BIOMARKER PROFILES
US8068990B2 (en) * 2003-03-25 2011-11-29 Hologic, Inc. Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
US7191068B2 (en) * 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
US20060157647A1 (en) * 2005-01-18 2006-07-20 Becton, Dickinson And Company Multidimensional liquid chromatography/spectrometry
KR20080006617A (ko) * 2005-04-15 2008-01-16 백톤 디킨슨 앤드 컴퍼니 패혈증의 진단
ATE549129T1 (de) * 2007-04-26 2012-03-15 Adept Technology Inc Vakuumgreifvorrichtung
US8669113B2 (en) 2008-04-03 2014-03-11 Becton, Dickinson And Company Advanced detection of sepsis
US7846678B2 (en) * 2008-08-18 2010-12-07 BioDtech, Inc. Enhancing endotoxin detection
EP2318836B1 (en) * 2008-09-04 2013-07-31 Beckman Coulter, Inc. Pan-kinase activation and evaluation of signaling pathways
CN104407156B (zh) * 2014-12-05 2016-03-16 重庆中元生物技术有限公司 检测多糖结合蛋白(lbp)的胶乳增强免疫比浊试剂盒及其制备方法
CN109507127A (zh) * 2018-12-07 2019-03-22 上海浩港生物技术有限公司 一种用于检测人类血液中lbp含量的试剂盒
CN109507323A (zh) * 2018-12-07 2019-03-22 上海浩港生物技术有限公司 一种用质谱仪检测人类血液中lbp含量的试剂盒

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5310879A (en) * 1985-04-30 1994-05-10 The Scripps Research Institute Antibodies which immunoreact with lapine lipopolysaccharide binding protein (LBP)
WO1986006279A1 (en) * 1985-04-30 1986-11-06 Scripps Clinic And Research Foundation Acute phase protein modulating endotoxic activity of lipopolysaccharides, compositions and methods
US5245013A (en) * 1985-04-30 1993-09-14 Richard Ulevitch Acute phase protein modulating endotoxic activity of lipopolysaccharides, assay methods and polypeptides
WO1994025476A1 (en) * 1993-04-30 1994-11-10 Incyte Pharmaceuticals, Inc. Recombinant bpi-based and lbp-based proteins, nucleic acid molecules encoding same, methods of producing same, and uses thereof
EP0485430B1 (en) * 1989-08-01 1998-09-16 The Scripps Research Institute Methods and compositions for ameliorating the symptoms of sepsis
JPH07502642A (ja) * 1991-09-26 1995-03-23 インサイト　ファーマシューティカルズ，インコーポレイテッド 新規な形態のリポ糖結合性タンパク質（ｌｂｐ）
WO1994021280A1 (en) * 1993-03-22 1994-09-29 Incyte Pharmaceuticals, Inc. Use of bactericidal/permeability increasing protein and lipopolysaccharide binding protein levels and ratios thereof in diagnosis
US5731415A (en) * 1993-06-17 1998-03-24 Xoma Corporation Lipopolysaccharide binding protein derivatives
WO1995002414A1 (en) * 1993-07-14 1995-01-26 Xoma Corporation Method for potentiating bpi protein product bactericidal activity by administration of lbp protein products
US5484705A (en) * 1994-01-24 1996-01-16 Xoma Corporation Method for quantifying lipopolysaccharide binding protein

Also Published As

Publication number Publication date
DE69510772T2 (de) 1999-11-11
ATE182216T1 (de) 1999-07-15
AU1732195A (en) 1995-08-08
US5804367A (en) 1998-09-08
US5484705A (en) 1996-01-16
ES2133738T3 (es) 1999-09-16
EP0741870B1 (en) 1999-07-14
MX9602688A (es) 1997-05-31
AU701710B2 (en) 1999-02-04
WO1995020163A1 (en) 1995-07-27
HK1015174A1 (en) 1999-10-08
CN1139485A (zh) 1997-01-01
CN1132013C (zh) 2003-12-24
US6274328B1 (en) 2001-08-14
GR3031303T3 (en) 1999-12-31
JPH09508465A (ja) 1997-08-26
DE69510772D1 (de) 1999-08-19
EP0741870A1 (en) 1996-11-13
JP3554331B2 (ja) 2004-08-18

Similar Documents

Publication Publication Date Title
DK0741870T3 (da) Fremgangsmåde til kvantificering af LBP i kropsvæsker
DE69938662D1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
EP0987550A3 (en) Analytical test device and method of use
NO973444L (no) Fremgangsmåter og forbindelser for magnetrelaksometrisk påvisning av analytter, samt anvendelse av slike
EA199800857A1 (ru) Композиция для снятия боли и способ снятия боли
BR9608448A (pt) Instrumentos eletrônicos de transferência de fundos.
DK0988534T3 (da) Elektroniske fremgangsmåder og apparat til detektering af analytter
DE69840025D1 (de) Assoziierter antworten
BR9907256A (pt) Inibidores beta-cetoamida de proteassoma 20s
ATE218227T1 (de) Eingabevorrichtung für ein rechnersystem
EA200300464A1 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
DE50201281D1 (de) Ölwanne mit integrierter Ölfiltereinheit
AU7260496A (en) A method and diagnostic test kit for use in aiding the diagnosis of fibromyyalgia and chronic fatigue syndrome (CFS)
DE59600580D1 (de) Verfahren zur lastmessung
WO2000018922A8 (en) Human carbohydrate-associated proteins
WO2000009709A3 (en) Proteases and associated proteins
DK0720745T3 (da) Fremgangsmåde til kvantificering af ekstracellulært BPI i legemsvæsker
AU8218591A (en) Method for reducing interference in a fluorescent assay
DK1179183T3 (da) Fremgangsmåde til identifikation af præneoplastiske og/eller neoplastiske tilstande hos pattedyr
WO2000028045A3 (en) Human hydrolase proteins
EA199700449A1 (ru) Способ предотвращения остеопороза
DE19881835T1 (de) Verfahren zur Übermittlung von Zahlungstransaktionen im Internet
DE69132144D1 (de) Menschliche phospholipase aktivierender proteinteil
CA2181815A1 (en) Method for quantifying lbp in body fluids
WO1998057986A3 (en) Human preprotachykinin b